Olle Christenson

Olle Christenson appears in our data through filings on Recipharm AB shares, published by Finansinspektionen. Over a trading history stretching from 16 November 2017 to 15 February 2021, the count stands at 11 filings.

In open-market terms, that means 4 purchases worth €3,102 on one side and 1 sale worth €151k on the other. Taken together, the sales exceed the purchases by €148k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 share grant. In 2021 alone, the filings show no purchases and 1 sale.

Half of the purchases are above €876 and half below. None of the 4 purchases we analysed coincided with buying by another insider of the same company within 30 days.

The latest filing, published on 15 February 2021, reports an open-market sale of €151k in Recipharm AB. The most recent open-market purchase was published on 29 July 2020, 2,292 days ago. The median gap between a trade and its publication by Finansinspektionen is 1 day. The regulation allows three business days to notify a trade (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.